How Cresud CRESY benefits from the shifts in its industry 071 20260508 MSTR Strategy Inc climbs 118 percent on positive investor sentiment despite steep Q4 2025 earnings miss AEM Agnico Eagle Q1 revenue surges 437 yearoveryear to 119B shares jump 29 on earnings beat Keros Therapeutics KROS Business Update Q4 2025 Earnings Underperform